Clinical Trial Update: Metformin and Its Impact on the Substances Associated With NO Production in Prediabetes Patients. [Phase 4]

View source ↗

Summary

Phase 4 trial examining how metformin affects substances related to nitric oxide production in adults with prediabetes and impaired fasting glucose.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Impaired Fasting Glucose
• Impaired Glucose Tolerance
• Prediabetes

Drugs mentioned

• metformin (metformin)

Snippet

Sponsor: Wroclaw Medical University | Conditions: PreDiabetes, Impaired Fasting Glucose (IFG) | Phase 4 | Status: COMPLETED | Results posted: 2020-08-24